A multi-center phase Ib trial of the histone deactylase inhibitor (HDACi) entinostat in combination with anti-pd1 antibody pembrolizumab in patients with refractory/relapsed myelodysplastic syndromes (RR-MDS) or oligoblastic acute myeloid leukemia (RR-AML) after hypomethylating agent (HMA) failure Meeting Abstract
| Authors: | Bewersdorf, J. P.; Shallis, R. M.; Sharon, E.; Caldwell, A.; Wei, W.; Yacoub, A.; Madanat, Y. F.; Zeidner, J. F.; Altman, J. K.; Odenike, O.; Yerrabothala, S.; Kovacsovics, T.; Podoltsev, N. A.; Halene, S.; Little, R. F.; Piekarz, R.; Gore, S. D.; Kim, T. K.; Zeidan, A. M. |
| Abstract Title: | A multi-center phase Ib trial of the histone deactylase inhibitor (HDACi) entinostat in combination with anti-pd1 antibody pembrolizumab in patients with refractory/relapsed myelodysplastic syndromes (RR-MDS) or oligoblastic acute myeloid leukemia (RR-AML) after hypomethylating agent (HMA) failure |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 9084 |
| End Page: | 9086 |
| Language: | English |
| ACCESSION: | WOS:000893230302037 |
| DOI: | 10.1182/blood-2022-158626 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
